R.E.A. Holdings plc (RE-B.L)
London, GB
Founded in London in 1906, R.E.A. Holdings plc primarily engages in the cultivation of oil palms across East Kalimantan, Indonesia. The company's agricultural operations yield both crude palm oil and crude palm kernel oil for sale. Beyond its farming activities, R.E.A. Holdings also holds substantial interests in the natural resources sector. This includes the extraction and sale of crushed stone, active participation in coal and sand mining, and the generation of sustainable energy from its methane capture facilities. These mining and energy assets, along with concessions for stone, sand, and coal, are also situated in East Kalimantan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.26% | +1.31% | -0.52% | -2.03% | +0.00% | +7.82% | +6.93% | +12.87% | +5.75% | +17.33% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Agricultural Farm Products: +8.2%+5.9% Q4'25: -0.1% (vs Q4'23)
-
EPS growth Agricultural Farm Products: +20.0%-101.7% Q4'25: +435.2% (vs Q4'23)
-
FCF margin FCF growth · Agricultural Farm Products: +43.8%+9.4% Q4'25: +17.7% (vs Q4'23)
-
EBIT margin Agricultural Farm Products: +8.1%+21.3% ★ Q4'25: +21.7% (vs Q4'23)
-
ROIC Agricultural Farm Products: +6.0%+5.6% Q4'25: +18.3% (vs Q4'23)
-
Share dilution Agricultural Farm Products: +0.0%+0.0% Q4'25: -0.2% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Agricultural Farm Products: 0.61×2.51× Q4'25: 1.96× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 1 EPS Ana. |
Dec 2027 3 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
83.14M
est.
|
97.99M
est.
|
119.25M
est.
|
124.99M
est: 121.82M (+2.6%)
|
139.09M
est: 136.73M (+1.7%)
|
191.91M
est: 191.49M (+0.2%)
|
208.78M
est: 212.20M (-1.6%)
|
176.72M
est: 175.45M (+0.7%)
|
187.94M
est: 188.00M (0.0%)
|
199.03M
est: 193.21M (+3.0%)
|
204.58M
198.00M – 211.16M
+5.9% YoY
|
217.60M
207.31M – 227.47M
+6.4% YoY
|
237.81M
228.31M – 247.08M
+9.3% YoY
|
| EBITDA |
26.39M
est.
|
31.10M
est.
|
37.85M
est.
|
15.65M
est: 38.67M (-59.5%)
|
33.22M
est: 43.40M (-23.4%)
|
72.67M
est: 60.78M (+19.6%)
|
66.47M
est: 67.35M (-1.3%)
|
40.98M
est: 55.69M (-26.4%)
|
78.80M
est: 70.62M (+11.6%)
|
70.00M
est: 72.58M (-3.6%)
|
76.85M
74.38M – 79.32M
+5.9% YoY
|
81.74M
77.87M – 85.45M
+6.4% YoY
|
89.33M
85.76M – 92.81M
+9.3% YoY
|
| EBIT |
14.53M
est.
|
17.13M
est.
|
20.84M
est.
|
-9.11M
est: 21.29M (-142.8%)
|
8.81M
est: 23.90M (-63.1%)
|
48.08M
est: 33.47M (+43.7%)
|
41.40M
est: 37.09M (+11.6%)
|
14.84M
est: 30.66M (-51.6%)
|
52.19M
est: 40.35M (+29.3%)
|
42.30M
est: 41.47M (+2.0%)
|
43.91M
42.50M – 45.32M
+5.9% YoY
|
46.71M
44.50M – 48.82M
+6.4% YoY
|
51.04M
49.01M – 53.03M
+9.3% YoY
|
| Net Income |
-16.29M
est.
|
-33.90M
est.
|
-10.14M
est.
|
-17.81M
est: -33.18M (+46.3%)
|
-13.60M
est: -2.36M (-475.9%)
|
7.33M
est: -1.10M (+765.3%)
|
27.78M
est: 14.12M (+96.7%)
|
-10.24M
est: -11.39M (+10.1%)
|
26.45M
est: 18.47M (+43.2%)
|
8.66M
est: 7.84M (+10.5%)
|
11.42M
10.83M – 12.00M
+45.7% YoY
|
15.22M
14.43M – 15.99M
+33.3% YoY
|
21.81M
20.68M – 22.92M
+43.3% YoY
|
| SGA |
8.21M
est.
|
9.67M
est.
|
11.77M
est.
|
17.45M
est: 12.02M (+45.1%)
|
18.78M
est: 13.49M (+39.2%)
|
14.19M
est: 18.90M (-24.9%)
|
19.12M
est: 20.94M (-8.7%)
|
18.88M
est: 17.32M (+9.0%)
|
16.18M
est: 16.76M (-3.4%)
|
17.35M
est: 17.22M (+0.8%)
|
18.23M
17.65M – 18.82M
+5.9% YoY
|
19.39M
18.48M – 20.27M
+6.4% YoY
|
21.20M
20.35M – 22.02M
+9.3% YoY
|
| EPS |
-0.37
est.
|
-0.77
est.
|
-0.23
est.
|
-0.43
est: -0.75 (+43.0%)
|
-0.31
est: -0.05 (-476.9%)
|
-0.03
est: -0.03 (-36.1%)
|
0.27
est: 0.32 (-15.9%)
|
-0.46
est: -0.26 (-77.5%)
|
0.42
est: 0.42 (0.0%)
|
-0.01
est: 0.18 (-103.9%)
|
0.26
0.25 – 0.27
+45.7% YoY
|
0.35
0.33 – 0.36
+33.3% YoY
|
0.50
0.47 – 0.52
+43.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-28 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-27 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-26 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-22 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-21 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-20 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-19 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-18 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-15 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-14 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-13 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-12 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-11 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-08 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-07 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-06 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-05 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-01 | B | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-30 | B | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-29 | B | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-28 | B | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-27 | B | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-23 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-22 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-21 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-20 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-17 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-16 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 4/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Carol Elizabeth Gysin | Executive Director | 612.7K | female |
| Richard Michael Robinow | Managing Director & Non-Executive Director | 137.0K | male |
| Luke Michael Devereux Robinow | Group MD & Executive Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for RE-B.L
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
